Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.,Genetic Epidemiology

当前位置： X-MOL 学术 › Genet. Epidemiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
Genetic Epidemiology ( IF 1.7 ) Pub Date : 2019-08-13 , DOI: 10.1002/gepi.22242
Lennox Din ₁ , Mohammad Sheikh ₁ , Nikitha Kosaraju ₂ , Karin Ekstrom Smedby ₃ , Sasha Bernatsky _{4,

5} , Sonja I Berndt ₆ , Christine F Skibola ₇ , Alexandra Nieters ₈ , Sophia Wang ₉ , James D McKay ₁₀ , Pierluigi Cocco ₁₁ , Marc Maynadié ₁₂ , Lenka Foretová ₁₃ , Anthony Staines ₁₄ , Thomas M Mack ₁₅ , Silvia de Sanjosé _{16,

17,

18} , Timothy J Vyse ₁₉ , Leonid Padyukov ₂₀ , Alain Monnereau _{21,

22} , Alan A Arslan ₂₃ , Amy Moore ₆ , Angela R Brooks-Wilson _{24,

25} , Anne J Novak ₂₆ , Bengt Glimelius ₂₇ , Brenda M Birmann ₂₈ , Brian K Link ₂₉ , Carolyn Stewart ₃₀ , Claire M Vajdic ₃₁ , Corinne Haioun ₃₂ , Corrado Magnani ₃₃ , David V Conti ₃₄ , David G Cox ₃₅ , Delphine Casabonne _{17,

18} , Demetrius Albanes ₆ , Eleanor Kane ₃₆ , Eve Roman ₃₆ , Giacomo Muzi ₃₇ , Gilles Salles ₃₈ , Graham G Giles _{39,

40} , Hans-Olov Adami _{41,

42} , Hervé Ghesquières ₃₈ , Immaculata De Vivo _{28,

43} , Jacqueline Clavel ₄₄ , James R Cerhan ₄₅ , John J Spinelli _{46,

47} , Jonathan Hofmann ₆ , Joseph Vijai ₃₀ , Karen Curtin ₄₈ , Karen H Costenbader ₂₈ , Kenan Onel ₄₉ , Kenneth Offit _{50,

51} , Lauren R Teras ₅₂ , Lindsay Morton ₆ , Lucia Conde ₅₃ , Lucia Miligi ₅₄ , Mads Melbye _{55,

56} , Maria Grazia Ennas ₅₇ , Mark Liebow ₂₆ , Mark P Purdue ₅₈ , Martha Glenn ₄₈ , Melissa C Southey _{59,

60} , Morris Din ₆₁ , Nathaniel Rothman ₆ , Nicola J Camp _{48,

62} , Nicole Wong Doo _{63,

64} , Nikolaus Becker ₆₅ , Nisha Pradhan ₃₀ , Paige M Bracci ₆₆ , Paolo Boffetta ₆₇ , Paolo Vineis ₆₈ , Paul Brennan ₁₀ , Peter Kraft ₆₉ , Qing Lan ₆ , Richard K Severson ₇₀ , Roel C H Vermeulen ₇₁ , Roger L Milne _{39,

40,

64} , Rudolph Kaaks ₇₂ , Ruth C Travis ₇₃ , Stephanie J Weinstein ₆ , Stephen J Chanock ₆ , Stephen M Ansell ₂₆ , Susan L Slager ₄₅ , Tongzhang Zheng ₇₄ , Yawei Zhang ₇₅ , Yolanda Benavente _{17,

18} , Zachary Taub ₇₆ , Lohith Madireddy ₇₇ , Pierre-Antoine Gourraud _{78,

79} , Jorge R Oksenberg ₇₇ , Wendy Cozen ₈₀ , Henrik Hjalgrim ₅₅ , Pouya Khankhanian ₂

Affiliation

College of Medicine, California Northstate University, Elk Grove, California.
Center for Neuroengineering and Therapeutics, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Division of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Solna, Sweden.
Faculty of Medicine, McGill University, Montreal, Canada.
Clinical Epidemiology, McGill University Health Centre, Research Institute, Montreal, Canada.
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
School of Medicine, Emory University, Atlanta, Georgia.
Centre of Chronic Immunodeficiency, University Medical Centre Freiburg, Freiburg im Breisgau, Germany.
Department of Population Sciences, City of Hope and the Beckman Research Institute, Duarte, California.
International Agency for Research on Cancer, Lyon, France.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Sardinia, Italy.
The University of Burgundy-Franche-Comté and CHU Dijon Bourgogne, Registre des Hémopathies Malignes de Côte d'Or, INSERM U1231, Dijon, France.
Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
School of Nursing and Human Science, Dublin City University, Dublin, Ireland.
Norris Comprehensive Cancer Center and Hospital, University of Southern California, Los Angeles, California.
Reproductive Health Global Program PATH, School of Public Health, University of Washington, Seattle, Washington, USA.
Unit of Infections and Cancer, Cancer Epidemiology Research Programme, Institut Català d' Oncologia, (IDIBELL), Barcelona, Spain.
Centro de Investigación Biomédica en Red, Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Medical and Molecular Genetics, King's College London, London, England.
Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Center of Research in Epidemiology and Statistics, Sorbonne (CRESS), Epidemiology of Childhood and Adolescent Cancer Group, INSERM, Paris, France.
Registre des Hémopathies Malignes de la Gironde, Institut Bergonie, Bordeaux, France.
Department of Obstetrics and Gynecology, Department of Population Health, Department of Environmental Medicine, NYU School of Medicine, New York, New York.
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada.
Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, Canada.
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Immunology, Genetics, and Pathology, Uppsala Universitet, Uppsala, Sweden.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.
Memorial Sloan Kettering Cancer Center, New York, New York.
Centre for Big Data Research in Health, University of New South Wales, Kensington, Australia.
Lymphoid Malignancies Unit, Henri Mondor Hospital, University Paris-Est Créteil (UPEC), Paris, France.
Medicina Traslazionale, Università del Piemonte Orientale, Vercelli, Italy.
Department of Preventive Medicine, University of Southern California, Los Angeles, Califonia.
Centre de Recherche en Cancerologie de Lyon, Lyon, France.
Department of Health Sciences, University of York, York, England.
Department of Medicine, Universita degli Studi di Perugia, Perugia, Italy.
Hematology Department, Centre Hospitalier Universitaire de Lyon, Lyon, France.
Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Clinical Effectiveness Research Group, Institute of Health, University of Oslo, Oslo, Norway.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Department of Environmental Epidemiology of Cancers, INSERM, Paris, France.
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Population Oncology, British Columbia Cancer Agency, Vancouver, Canada.
School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Internal Medicine, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake, Utah.
Department of Pediatrics, University of Chicago, Chicago, Illinois.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York.
Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia.
Bill Lyons Informatics Centre, UCL Cancer Institute, University College London Cancer Institute, London, England.
Environmental and Occupational Epidemiology Branch, Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research Prevention and Clinical Network (ISPRO), Florence, Florence, Italy.
Department of Epidemiology Research, Statens Serum Institut, København, Denmark.
School of Medicine, Stanford University, Stanford, California.
School of Biomedical Sciences, University of Calgary, Calgary, Canada.
Division of Cancer Biology, National Cancer Institute, Bethesda, Maryland.
Department of Clinical Pathology, Genetic Epidemiology Laboratory, University of Melbourne, Melbourne, Australia.
Precision Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
California State University, Sacramento, Califonia.
Department of Biomedical Informatics, University of Utah, Salt Lake, Utah.
Clinical School, Concord Hospital, University of Sydney, Sydney, Australia.
Centre for Epidemiology and Intelligence, Cancer Council Australia, Melbourne, Australia.
Division of Cancer Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
School of Public Health, Imperial College London, London, England.
Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Boston, Massachusetts.
Department of Family Medicine and Public Health Sciences, Wayne State University, Detroit, Michigan.
Division of Environmental Epidemiology, Institute for Risk Assessment Science, Utrecht University, Utrecht, Netherlands.
Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Cancer Epidemiology Unit, University of Oxford, Oxford, England.
School of Public Health, Brown University, Providence, Rhode Island.
Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut.
University of California, Davis, California.
Department of Neurology, University of California, San Francisco, California.
Centre de Recherche en Transplantation et Immunologie, Université de Nantes, Centre Hospitalier Universitaire (CHU, INSERM), Nantes, France.
Santé Publique, Clinique des Données, Centre Hospitalier Universitaire (CHU) de Nantes, INSERM, Nantes, France.
Departments of Preventive Medicine and Pathology, Norris Comprehensive Cancer Center and Hospital, University of Southern California, Los Angeles, California.

Epidemiologic studies show an increased risk of non-Hodgkin lymphoma (NHL) in patients with autoimmune disease (AD), due to a combination of shared environmental factors and/or genetic factors, or a causative cascade: chronic inflammation/antigen-stimulation in one disease leads to another. Here we assess shared genetic risk in genome-wide-association-studies (GWAS). Secondary analysis of GWAS of NHL subtypes (chronic lymphocytic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma) and ADs (rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis). Shared genetic risk was assessed by (a) description of regional genetic of overlap, (b) polygenic risk score (PRS), (c)"diseasome", (d)meta-analysis. Descriptive analysis revealed few shared genetic factors between each AD and each NHL subtype. The PRS of ADs were not increased in NHL patients (nor vice versa). In the diseasome, NHLs shared more genetic etiology with ADs than solid cancers (p = .0041). A meta-analysis (combing AD with NHL) implicated genes of apoptosis and telomere length. This GWAS-based analysis four NHL subtypes and three ADs revealed few weakly-associated shared loci, explaining little total risk. This suggests common genetic variation, as assessed by GWAS in these sample sizes, may not be the primary explanation for the link between these ADs and NHLs.

中文翻译：

自身免疫性疾病和非霍奇金淋巴瘤亚型之间的遗传重叠。

流行病学研究表明，自身免疫性疾病 (AD) 患者患非霍奇金淋巴瘤 (NHL) 的风险增加，这是由于共同的环境因素和/或遗传因素的组合，或因果级联：慢性炎症/抗原刺激之一疾病导致另一种疾病。在这里，我们评估全基因组关联研究（GWAS）中的共同遗传风险。 NHL亚型（慢性淋巴细胞白血病、弥漫性大B细胞淋巴瘤、滤泡性淋巴瘤和边缘区淋巴瘤）和AD（类风湿性关节炎、系统性红斑狼疮和多发性硬化症）的GWAS二次分析。通过(a)重叠区域遗传的描述、(b)多基因风险评分(PRS)、(c)“疾病”、(d)荟萃分析来评估共有遗传风险。描述性分析显示每种 AD 和每种 NHL 亚型之间几乎没有共同的遗传因素。 NHL 患者的 AD 的 PRS 并未增加（反之亦然）。在疾病中，与实体癌相比，NHL 与 AD 具有更多的共同遗传病因 (p = .0041)。荟萃分析（将 AD 与 NHL 结合起来）表明细胞凋亡基因和端粒长度有关。这项基于 GWAS 的分析对四种 NHL 亚型和三种 AD 进行了分析，结果显示几乎没有弱相关的共享基因座，这几乎无法解释总风险。这表明通过 GWAS 在这些样本量中评估的常见遗传变异可能不是这些 AD 和 NHL 之间联系的主要解释。

更新日期：2019-11-01

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11